President Trump on Tuesday announced that Pfizer had agreed to sell its products in the U.S. at "Most Favored Nation" pricing, one day after the administration required companies to respond to his prescription drug pricing executive order.

Drugmakers were given until Sept. 29 to respond to Trump's "Most Favored Nation" Executive Order that required companies sell drugs in the U.S. at the lowest price they sell in other developed countries, establish direct-to-consumer avenues and not sell new drugs for lower prices in other countries.

"Pfizer is committing to offer all of their prescription medications to Medicaid. it will be at the most favored nation's prices. It's going to have a huge impact on bringing Medicaid costs down like nothing else," Trump said in a press briefing in the Oval

See Full Page